Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.40 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | MET | P08581 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL641967 | 1.00 | TSHR (0.40) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL4613762 | 1.00 | TSHR (0.40) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL4964887 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL7359458 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL7924907 | 0.97 | OPRM1 (0.39) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL5081429 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL7572979 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL3711846 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL3708728 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT | |
| SCHEMBL541617 | 0.97 | OPRM1 (0.43) | TSHROPRM1OPRK1OPRL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116807912-A | Use of volatile components to limit or eliminate perception of malodor | 弗门尼舍有限公司 | 2023-09-29 | — | — | CN | claimed |
| US-11278011-B1 | Degradation of off-flavor compounds in aquaculture systems | UNIVERSITY OF SOUTH FLORIDA (US) | 2022-03-22 | — | — | US | claimed |
| CN-108138081-A | Spice composition | 奇华顿股份有限公司 | 2018-06-08 | — | — | CN | claimed |
| US-20260118840-A1 | MULTI SENSOR ARRAY SMART PLUG | WELLNUO LLC (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2025262046-A1 | METHODS OF DETERMINING SUSCEPTIBILITY OF OLFACTORY RECEPTOR LIGANDS TO ADAPTATION | FIRMENICH SA (CH) | 2025-12-26 | — | — | WO | disclosed |
| WO-2025014633-A2 | MULTI SENSOR ARRAY SMART PLUG FOR HEALTH AND HABIT TRACKING | WELLNUO LLC (US) | 2025-01-16 | — | — | WO | disclosed |
| CN-116807912-A | Use of volatile components to limit or eliminate perception of malodor | 弗门尼舍有限公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-111432851-B | Use of volatile components to limit or eliminate perception of malodor | 弗门尼舍有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-111032095-B | Method for identifying compounds capable of modulating laundry malodor, mold malodor, and/or sweat malodor | 弗门尼舍有限公司 | 2022-07-01 | — | — | CN | disclosed |
| US-20220170653-A1 | BUSINESS FACILITY WITH AN EXTERIOR MICROBIOME | PHYLAGEN, INC. (US) | 2022-06-02 | — | — | US | disclosed |
| US-11278011-B1 | Degradation of off-flavor compounds in aquaculture systems | UNIVERSITY OF SOUTH FLORIDA (US) | 2022-03-22 | — | — | US | disclosed |
| US-5426237-A | Oxidation of straight, branched or cyclic alkanes and benzene derivatives in presence of transition metal catalyst and aldehyde | SUMITOMO CHEMICAL CO., LTD. (JP) | 1995-06-20 | — | — | US | disclosed |
| EP-0531715-A1 | Process for producing alcohols and ketones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-03-17 | — | — | EP | disclosed |
| US-4466898-A | Methyl substituted oxobicyclo-4,4,0-decane derivatives, process for preparing same and organoleptic uses thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1984-08-21 | — | — | US | disclosed |
| US-4431680-A | FOODS; CHEWING GUM; DENTRIFICES; DRUGS; PERFUMES; TOBACCO; COSMETICS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1984-02-14 | — | — | US | disclosed |
| US-4431843-A | FOODS; CHEWING GUM; DENTIFRICES; TOBACCO | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1984-02-14 | — | — | US | disclosed |
| US-4387048-A | Methyl substituted oxobicyclo-4,4,0-decane derivatives and organoleptic uses thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1983-06-07 | — | — | US | disclosed |
| US-4377714-A | SALT FORMATION OF THE KETONE DERIVATIVE, HYDROLYSIS TO THE HYDROXY DERIVATIVE | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1983-03-22 | — | — | US | disclosed |
| US-4339467-A | Flavoring with methyl substituted oxobicyclo-4,4,0-decane derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1982-07-13 | — | — | US | disclosed |
| US-4320772-A | Methyl substituted oxobicyclo-4,4,0-decane derivatives, process for preparing same and organoleptic uses thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1982-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260118840-A1 | MULTI SENSOR ARRAY SMART PLUG | TAS2R16, TAS2R4, TAS2R41 | TSHR 357/4885OPRM1 1498/4885OPRK1 2595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.